Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (771-780 of 903) with videos related to

Pageof 91
Sort By:
The Lancet. Neurology|October 12, 2010
Revising the definition of Alzheimer's disease: a new lexiconBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2012
Impact of molecular imaging on the diagnostic process in a memory clinicRik Ossenkoppele, Niels D Prins, Yolande A L Pijnenburg, et al.
Journal of the American Medical Directors Association|August 29, 2015
Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conferenceJohn E Morley, John C Morris, Marla Berg-Weger, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 5, 2020
Circulating metabolites are associated with brain atrophy and white matter hyperintensitiesFrancisca A de Leeuw, Hata Karamujić-Čomić, Betty M Tijms, et al.
Clinical Proteomics|January 1, 2020
The plasma peptides of breast versus ovarian cancerJaimie Dufresne, Pete Bowden, Thanusi Thavarajah, et al.
Neurology|September 25, 2023
Performance of a [<sup>18</sup>F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy BodiesEmma M Coomans, Lotte A de Koning, Roos M Rikken, et al.
Alzheimer'S Research & Therapy|January 8, 2020
Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settingsLisa Vermunt, Graciela Muniz-Terrera, Lea Ter Meulen, et al.
Epigenomics|June 26, 2015
DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohortsLeonidas Chouliaras, Gunter Kenis, Pieter Jelle Visser, et al.
Frontiers in Aging Neuroscience|January 9, 2019
Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [<sup>18</sup>F]-Flutemetamol PET Scan ResultSarah Westwood, Alison L Baird, Abdul Hye, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 25, 2025
Unveiling blood biomarkers for neuronal hyperplasticity: Insights from AD molecular subtyping, a comprehensive reviewNiti Sharma, Danyeong Kim, Himadri Sharma, et al.
Pageof 91

Showing results (771-780 of 903) with videos related to

Sort By:
Pageof 91
The Lancet. Neurology|October 12, 2010
Revising the definition of Alzheimer's disease: a new lexiconBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2012
Impact of molecular imaging on the diagnostic process in a memory clinicRik Ossenkoppele, Niels D Prins, Yolande A L Pijnenburg, et al.
Journal of the American Medical Directors Association|August 29, 2015
Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conferenceJohn E Morley, John C Morris, Marla Berg-Weger, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 5, 2020
Circulating metabolites are associated with brain atrophy and white matter hyperintensitiesFrancisca A de Leeuw, Hata Karamujić-Čomić, Betty M Tijms, et al.
Clinical Proteomics|January 1, 2020
The plasma peptides of breast versus ovarian cancerJaimie Dufresne, Pete Bowden, Thanusi Thavarajah, et al.
Neurology|September 25, 2023
Performance of a [<sup>18</sup>F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy BodiesEmma M Coomans, Lotte A de Koning, Roos M Rikken, et al.
Alzheimer'S Research & Therapy|January 8, 2020
Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settingsLisa Vermunt, Graciela Muniz-Terrera, Lea Ter Meulen, et al.
Epigenomics|June 26, 2015
DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohortsLeonidas Chouliaras, Gunter Kenis, Pieter Jelle Visser, et al.
Frontiers in Aging Neuroscience|January 9, 2019
Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [<sup>18</sup>F]-Flutemetamol PET Scan ResultSarah Westwood, Alison L Baird, Abdul Hye, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 25, 2025
Unveiling blood biomarkers for neuronal hyperplasticity: Insights from AD molecular subtyping, a comprehensive reviewNiti Sharma, Danyeong Kim, Himadri Sharma, et al.
Pageof 91